Articles from Serenity Medical
Long-term data reinforce durability of venous sinus stenting as an evidence-backed, FDA-approved treatment option
By Serenity Medical · Via GlobeNewswire · July 22, 2026
Second FDA Regulatory Milestone for Serenity’s Novel Platform, Following the Recent HDE Approval of the River Stent™ – First Venous Stent for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)
By Serenity Medical · Via GlobeNewswire · June 30, 2026
Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy
By Serenity Medical · Via GlobeNewswire · March 31, 2026